The California Institute for Regenerative Medicine (CIRM) recently approved nearly $31 million in funding, further cementing our commitment to advancing the field of regenerative medicine. This substantial investment aims to drive clinical research targeting various cancers and eye diseases. CIRM’s dedication to fostering innovative treatments is demonstrated through its clinical program, which funds eligible stem … Continue reading CIRM’s $31 million boost for cancer and eye disease research
Disease Areas
Tackling sickle cell disease from within
Photo Credit: Jaquell Chandler Evie Junior was born with sickle cell disease, a life-threatening condition that affects around 100,000 Americans, most of them Black and Latino. People with sickle cell disease have blood cells that are shaped like a hook (or sickle) rather than smooth and round, which can create clogs, causing intense pain, organ … Continue reading Tackling sickle cell disease from within
How CIRM is moving to raise awareness of Parkinson’s Disease
Crissy Field was filled with vibrant colors and massive energy for the 10th annual Moving Day San Francisco event on Saturday, May 4th. Even with the rain and wind, community members showed up to demonstrate their commitment to "moving to end Parkinson's." Moving Day is an annual fundraising walk that unites people living with Parkinson’s Disease, their caregivers, and … Continue reading How CIRM is moving to raise awareness of Parkinson’s Disease
CIRM awards $1.5 million in lung health study for patients with Down Syndrome
Stock image of the Trisomy 21 chromosome The California Institute for Regenerative Medicine (CIRM) recently awarded $1.5 million to Denise Al Alam, PhD, of the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center to support research that aims to understand lung disease in individuals with Trisomy 21, also known as Down Syndrome.Although Trisomy 21 … Continue reading CIRM awards $1.5 million in lung health study for patients with Down Syndrome
State agency launches ‘Championing Change for Sickle Cell in California’ campaign
The California Institute for Regenerative Medicine (CIRM), established by the voters of California, is accelerating research and awareness of Sickle Cell Disease. The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, is proud to announce the launch of "Championing Change for Sickle Cell in California,” a pioneering … Continue reading State agency launches ‘Championing Change for Sickle Cell in California’ campaign
Identifying a Potential New Stem Cell Treatment for Ovarian Cancer
Stock image of a uterus and ovaries model. The California Institute for Regenerative Medicine (CIRM) has awarded a $5.3 million to Karen Aboody, MD of City of Hope for late-stage preclinical research to develop a neural stem cell mediated treatment for a chemo-resistant, metastatic ovarian cancer. Approximately 22,000 women are diagnosed with ovarian cancer—the most … Continue reading Identifying a Potential New Stem Cell Treatment for Ovarian Cancer
CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s
Stock image of Parkinson's disease nerve cells. The California Institute for Regenerative Medicine (CIRM) has approved an $8 million award to Aspen Neuroscience to advance an investigational stem cell-derived dopaminergic neuron replacement therapy for Parkinson’s disease (PD). This individualized potential therapy is being explored in a first-in-human Phase 1/2a clinical trial for patients with moderate … Continue reading CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s
Celebrating Black Joy and Spreading Awareness
The streets of Oakland were alive with vibrant colors, infectious energy, and a powerful sense of community as the 2024 Black Joy Parade took center stage on Sunday, February 25. Black Joy Parade-goers with colorful noisemakers walking down Franklin and 19th St. The Black Joy Parade is a yearly celebration of the Black community and … Continue reading Celebrating Black Joy and Spreading Awareness
Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial
Photo Courtesy of Neurona Therapeutics/Curtis Myers Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, recently announced the successful completion of a $120 million financing. Neurona’s financial success is an encouraging sign for the stem cell and gene therapy sector, highlighting partnerships with investors and public organizations … Continue reading Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial
CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
Stock image of a dual tone brain by Getty Images South San Francisco, CA, Jan. 29, 2024 - The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded almost $26 million to fund various clinical research — from treating bipolar depression to advancing a therapy for spinal cord injury. … Continue reading CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
The Stem Cellar 